Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial.
Lancet Oncol
; 15(13): 1460-1468, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-25456365
Full text:
1
Database:
MEDLINE
Main subject:
Osteoporosis
/
Triazoles
/
Bone Density
/
Etidronic Acid
/
Postmenopause
/
Bone Density Conservation Agents
/
Nitriles
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Year:
2014
Type:
Article